ARTICLE | Company News

Shire sales and marketing update

July 28, 2008 7:00 AM UTC

Shire launched Vyvanse lisdexamfetamine in the U.S. to treat ADHD in adults. At the same time, Shire introduced 20, 40 and 60 mg capsules. The company already markets 30, 50 and 70 mg capsules. The a...